The adiponectin role in pathogenesis of metabolic syndrome and cardiovascular disease

Agnieszka Kozłowska; Irina Kowalska

Vol 57, No 6 (2006)

Review paper

Submitted: 2013-02-15

Published online: 2006-11-29

View PDF (Polish)

Download PDF file

Get Citation

The adiponectin role in pathogenesis of metabolic syndrome and cardiovascular disease

Agnieszka Kozłowska, Irina Kowalska

Endokrynol Pol 2006;57(6):626-632.

Vol 57, No 6 (2006)

Review Article

Submitted: 2013-02-15

Published online: 2006-11-29

Abstract

The aim of this review is to present the up-to-date data about adiponectin and it’s role in pathogenesis of cardiovascular disease. Adiponectin is a hormone derived from adipose tissue which regulates energy metabolism, and plays an important role in the pathogenesis of insulin resistance. Serum levels of adiponectin are reduced in obesity, hypertension, metabolic syndrome and type 2 diabetes. Moreover, plasma adiponectin concentration is inversely associated with LDL-cholesterol, TG and is positively related to HDLcholesterol. Recent studies have indicated that adiponectin has antiinflammatory and antiatherogenic properties. Review of the data confirmed the hypothesis that adiponectin plays an important role in pathogenesis of cardiovascular disease.